Biotechnology

Far Eastern New Century won the "Sustainability & Innovation Award" from ITMF Awards 2022 with FENC® TOPGREEN® Bio3

FENC® TOPGREEN® Bio3, World No.1 Fabric made from waste gas reuse technology & N66 solution dye. TAIPEI, Sept. 21, 2022 /PRNewswire/ -- As the pioneer in innovation and sustainability, Far Eastern New Century Corporation (FENC) is able to provide solutions to lower the environmental impact for b...

2022-09-21 20:00 2032

HIKE Capital rides green wave to seize future

BEIJING and SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- As the world is undergoing an energy restructuring, HIKE Capital, a leading founders' fund in China, has been committed to seizing the opportunities that emerged in the new era, which has been shaped by carbon reduction and digital technology. ...

2022-09-21 13:53 1922

Excelra partners with Patcore, Inc.

The partnership expands Excelra's scientific products footprint in the Japanese market HYDERABAD, India and TOKYO, Sept. 21, 2022 /PRNewswire/ -- Excelra today announced a partnership with Patcore, Inc., providing greater access to Excelra's scientific data and analytics products for customers i...

2022-09-21 12:30 3206

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd (SCG), has announced today the establishment of a state-of-the-art cell therapy research and manufacturing hub inSingapore. With the support of the Singapore Economic Development Board (EDB), the hub comprises a pi...

2022-09-21 11:00 2930

Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data

MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[131I] iodo-phenylalanine, or 131 I-IPA) in combination with external beam radiation therapy (EBRT)...

2022-09-21 07:51 1385

GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

PALO ALTO, Calif., Sept. 20, 2022 /PRNewswire/ -- Koji Tanabe of I Peace, Inc. ( https://www.ipeace.com ) and a researcher Hiroko Nobuta of theUniversity of California, San Francisco (currently assistant professor at Rutgers University) successfully achieved the direct repr...

2022-09-21 05:39 1178

Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment

GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluatin...

2022-09-21 05:33 1432

Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy

Regulatory Authorization Granted to Proceed with ATH434 Phase 2 Clinical Trial MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tr...

2022-09-20 19:25 1465

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...

2022-09-20 17:00 2499

Jialian Biotech Group To Participate At Vitafoods Asia 2022 In Bangkok

TAIPEI, Sept. 20, 2022 /PRNewswire/ -- Leading Taiwanese health-care supplements manufacturer Jialian Biotech Group (Jialian) is excited to announce its participation in Vitafoods Asia 2022 –Asia's leading nutraceutical event – inBangkok from October 5th to October 7th, 2022.  Headquartered in T...

2022-09-20 14:01 2041

WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA

WUXI, China, Sept. 20, 2022 /PRNewswire/ --WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received reg...

2022-09-20 10:48 1922

Angel Yeast Launches Premium Dry Yeast to Cater to Changing Global Baking Needs at Bakery China 2022

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer announces that it has developed the latest dry yeast product Premium Dry Yeast to address many of today's baking challenges at Bakery China 2022 -- a global large...

2022-09-20 10:47 3301

Special interview with Dr. Patrick Yu-Wai-Man on International LHON Awareness Day

WUHAN, China and SAN DIEGO, Sept. 19, 2022 /PRNewswire/ -- September 19th is International LHON Awareness Day. LHON is a debilitating disease that leads to quick vision loss concomitantly or successively. It mostly impacts young adolescent males and brings tremendous physical and psychological st...

2022-09-19 20:00 2389

Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium

SINGAPORE, Sept. 19, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced thatJerome Boyd-Kirkup, Ph.D., Hummingbird Bioscience's Chief Scientific Offic...

2022-09-19 20:00 1415

MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* with Mid to Low Range Throughput

SHENZHEN, China, Sept. 19, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. As one of the sequencers* with the fastest speed among those with the same throughput in the world,...

2022-09-19 20:00 2131

Asia's first industrial insect company, Nutrition Technologies, closes US$20m equity round to launch new products and expand into new markets

SINGAPORE, Sept. 19, 2022 /PRNewswire/ -- On 19th September 2022 Nutrition Technologies completed an equity venture round ofUS$ 20m. The round was led by PTT Ventures and supported by Sumitomo Corporation, ING Sustainable Investments, Mandala Capital, as well as continued participation from exist...

2022-09-19 16:34 1796

Anyong Biotechnology's Locally Sourced 'Santé Silver Perch Essence' Fulfilling Increasing Demand in The APAC Wellness Industry

KAOHSIUNG, Taiwan, Sept. 19, 2022 /PRNewswire/ -- Taiwan-based Anyong Biotechnology, has created a locally-sourced Santé Silver Perch Essence out of ecologically farmed, certified, and traceable silver perch in major markets such asTaiwan, the United States, Singapore, and Malaysia. As consumers'...

2022-09-19 16:30 2030

Taiwan's Anyong Biotechnology First To Employ Seafood Stem-Cell Freezing

KAOHSIUNG, Taiwan, Sept. 19, 2022 /PRNewswire/ -- Anyong Biotechnology, the world-class aquatic food processing company based inTaiwan, is now the first company in the region to employ Cells Alive System (CAS) technology fromJapan. It ranks as the most advanced freezing technology inAsia and is a...

2022-09-19 16:20 1392

MagicTouch SCB receives IDE approval for In-Stent Restenosis indication

TAMPA, Fla., Sept. 19, 2022 /PRNewswire/ -- The US FDA has granted an Investigational Device Exemption (IDE) approval forMagicTouch  Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR).

2022-09-19 12:20 2182

Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA

SHANGHAI and BUCKS COUNTY, Pa., Sept. 20, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines ...

2022-09-19 09:34 1824
1 ... 151152153154155156157 ... 307